Hydrochlorothiazide
Who holds supplier records for Hydrochlorothiazide? 18 organisations hold a current record for Hydrochlorothiazide: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), China (3), Netherlands (1), Italy (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Hydrochlorothiazide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hydrochlorothiazide
Reading the evidence
- 18 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
12 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Hydrochlorothiazide expires 23 Jan 2044. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (18)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydrochlorothiazide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 18563, 16707 · latest filing Nov 2005
- TAPI NL BVNetherlandsCEPActive DMF 4028, 2115 · latest filing Dec 1980
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 20534, 16278, 6237 · latest filing Apr 2007
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 22253 · latest filing Nov 2008
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 17728 · latest filing Sept 2004
- CAMBREX PROFARMACO MILANO SRLItalyCEP Company GMP cert on recordActive DMF 881 · latest filing Jan 1965
- CHANGZHOU PHARMACEUTICAL FACTORYChinaCEP Company GMP cert on recordActive DMF 16750, 4924 · latest filing Aug 2003
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 41889 · latest filing Aug 2025
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 33923 · latest filing Jun 2019
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 17599 · latest filing Aug 2004
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 22541 · latest filing Jan 2008
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 25849 · latest filing Mar 2012
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 21039 · latest filing Nov 2007
- VALENS MOLECULES PRIVATE LTDIndiaActive DMF 19721 · latest filing Aug 2006
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 22027 · latest filing Sept 2008
- IndiaCEP
- IndiaCEP
- Suzhou Lixin Pharmaceutical Co., Ltd.ChinaCEPInactive DMF 21181 · latest filing Dec 2007
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Hydrochlorothiazide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 25 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2009-103 - Rev 06 Hydrochlorothiazide | Aug 2025 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2016-012 - Rev 02 Hydrochlorothiazide, Form-I | May 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2001-304 - Rev 13 Hydrochlorothiazide | May 2025 | — |
| Changzhou Pharmaceutical Factory Changzhou | CN | CEP 2006-011 - Rev 05 Hydrochlorothiazide | Jan 2025 | Inspected Apr 2025 Italy |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2023-218 - Rev 00 Hydrochlorothiazide, Regular and micronised grade | Dec 2024 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2020-017 - Rev 01 Hydrochlorothiazide, Process 2 | Nov 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2023-466 - Rev 01 Hydrochlorothiazide, Process-II | Sept 2024 | — |
| ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański | PL | CEP 2004-058 - Rev 06 Hydrochlorothiazide, Standard grade, micronised grade | Apr 2024 | Inspected Jul 2026 Poland |
| CAMBREX PROFARMACO MILANO S.R.L. Paullo | IT | CEP 2004-307 - Rev 07 Hydrochlorothiazide | Feb 2024 | Inspected Sept 2025 Italy |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2021-088 - Rev 00 Hydrochlorothiazide | Jan 2024 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2009-060 - Rev 02 Hydrochlorothiazide | Nov 2023 | Inspected May 2026 Italy |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2006-100 - Rev 02 Hydrochlorothiazide, Process II | Sept 2023 | — |
| SUZHOU LIXIN PHARMACEUTICAL CO., LTD. Suzhou | CN | CEP 2012-250 - Rev 02 Hydrochlorothiazide | Sept 2023 | Inspected Aug 2023 France, outside 3-year window |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | R1-CEP 2008-021 - Rev 05 Hydrochlorothiazide | Aug 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Hydrochlorothiazide are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactive DMF 6055, 4508 · filed Sept 1985
- SMITHKLINE AND BECKMAN INCInactive DMF 5614 · filed Dec 1984
- CHINOIN PHARMACEUTCIAL AND CHEMICAL WORKS CO LTDInactive DMF 5125 · filed Nov 1983
- LABORATORIOS JULIAN DE MEXICO SAInactive DMF 4488 · filed Apr 1982
- MICRO CHEMS LTDInactive DMF 1059 · filed May 1967
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (30 listed products contain Hydrochlorothiazide). The latest listed patent expires 23 Jan 2044. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Hydrochlorothiazide is a diuretic medication used to treat high blood pressure and swelling due to fluid build-up. It helps reduce excess fluid in the body and aids in lowering blood pressure.
Chemical identity
- IUPAC name
- 6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide
- Canonical SMILES
- C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
- InChIKey
- JZUFKLXOESDKRF-UHFFFAOYSA-N
- Synonyms
- HCTZ, hydrochlorothiazide, Esidrix, Hypothiazide, Vetidrex, Hidrotiazida, Idrotiazide, Megadiuril, Servithiazid, Newtolide, Oretic, Chlorosulthiadil
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Thiazide Diuretic
- Physiologic effect
- Increased Diuresis
- Chemical structure
- Thiazides
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Hydrochlorothiazide?
18 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydrochlorothiazide: Ipca Laboratories Limited (India), TAPI NL BV (Netherlands), Unichem Laboratories Ltd. (India), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), CAMBREX PROFARMACO MILANO SRL (Italy), CHANGZHOU PHARMACEUTICAL FACTORY (China) and Laurus Labs Limited (India), and 10 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Hydrochlorothiazide Drug Master Files are active?
Ipca Laboratories Limited (DMF 18563, 16707), TAPI NL BV (DMF 4028, 2115), Unichem Laboratories Ltd. (DMF 20534, 16278), Alembic Pharmaceuticals Limited (DMF 22253), APITORIA PHARMA PRIVATE LTD (DMF 17728), CAMBREX PROFARMACO MILANO SRL (DMF 881), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 16750, 4924) and Laurus Labs Limited (DMF 41889) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Hydrochlorothiazide records mean?
5 organisations have only inactive Type II DMFs for Hydrochlorothiazide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Hydrochlorothiazide have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Hydrochlorothiazide on the EDQM register, including ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), AMOLI ORGANICS PRIVATE LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL), Changzhou Pharmaceutical Factory Changzhou (CN), LAURUS LABS LIMITED Hyderabad (IN) and UNICHEM LABORATORIES LIMITED Mumbai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Hydrochlorothiazide?
Yes. The latest patent listed for an approved US product containing Hydrochlorothiazide expires 23 Jan 2044, across 30 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Hydrochlorothiazide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Hydrochlorothiazide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.